Heikki Kauma Selected Research

Heikki Kauma Research Topics

5	Atherosclerosis 07/2009 - 12/2002
2	Hantavirus Infections 02/2014 - 01/2013
2	Infections 04/2005 - 07/2002
1	Pneumonia (Pneumonitis) 03/2024
1	Encephalitis (Encephalitis, Rasmussen) 11/2020
1	Non-alcoholic Fatty Liver Disease 01/2017
1	Allergic Rhinitis 10/2010
1	Asthma (Bronchial Asthma) 10/2010
1	Chronic Renal Insufficiency 07/2009
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2009
1	Renal Insufficiency (Renal Failure) 07/2009
1	Myocardial Infarction 01/2009
1	Hemorrhagic Fever with Renal Syndrome (HFRS) 11/2007
1	Community-Acquired Infections 04/2005
1	Sepsis (Septicemia) 04/2005
1	Hypertension (High Blood Pressure) 10/2003
1	Insulin Resistance 10/2003
1	Type 2 Diabetes Mellitus (MODY) 10/2003
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2002
1	Combined Pituitary Hormone Deficiency 07/2002
1	Hemorrhage 07/2002

1	Anti-Bacterial Agents (Antibiotics)IBA 03/2024
1	Toll-Like Receptor 3IBA 11/2020
1	Phospholipases (Phospholipase)IBA 01/2017
1	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2014
1	NeopterinIBA 01/2013
1	C-Reactive ProteinIBA 10/2010
1	oxidized low density lipoproteinIBA 07/2009
1	LDL Lipoproteins (beta Lipoproteins)IBA 07/2009
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2009
1	RNA (Ribonucleic Acid)IBA 11/2007
1	Second Generation CephalosporinsIBA 04/2005
1	Coloring Agents (Dyes)IBA 04/2005
1	Aryldialkylphosphatase (Paraoxonase)IBA 12/2004
1	GhrelinIBA 10/2003
1	Insulin (Novolin)FDA Link 10/2003
1	Apolipoproteins E (ApoE)IBA 12/2002
1	ApolipoproteinsIBA 12/2002
1	Viral AntigensIBA 07/2002
1	AntigensIBA 07/2002

1	Tonsillectomy 10/2010
1	Therapeutics 04/2005